Track topics on Twitter Track topics that are important to you
3636 Westown Parkway, Suite 203
West Des Moines
United States of America
Several brokerages have updated their recommendations and price targets on shares of Icon in the last few weeks: 1/24/2018 - Icon was given a new $109.00 price target on by analysts at Mizuho. They no...
ICON Media ContactDeena MistryWeber Shandwick+44 (0)207 067 0387DMistry@webershandwick.com Read more...
ICON Press Office EnquiriesWeber ShandwickOlivia PimentaEmail: LDNWSWICONClinical@corp.ipgnetwork.com Read more...
They now have a $131.00 price target on the stock. 2/15/2018 - Icon had its "neutral" rating reaffirmed by analysts at Mizuho.
They now have a $120.00 price target on the stock, up previously from $105.00. 10/12/2017 - Icon Plc had its "buy" rating reaffirmed by analysts at Robert W. Baird.
ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, announced the launch of FIRECREST Pre-Screen, an innovative digi...
US-based Cancer Genetics (CGI) has collaborated with the Indian Cooperative Oncology Network (ICON) to minimise cancer mortality rates by optimising...Read More... The post Cancer Genetics and ICON to...
Icon plc has launched a new digital solution aimed at increasing the efficiency and quality of patient eligibility assessments as the industry continues to struggle with clinical trial recruitment.
Sure Aerosol Antiperspirant Deodorant Unscented
Sure Aerosol Antiperspirant Deodorant Regular Scent
Ammens Medicated Powder Shower Fresh Formula
Ammens Medicated Powder
Brut Anti-perspirant and Deodorant
Electron tomography (ET) plays an important role in studying in situ cell ultrastructure in three-dimensional space. Due to limited tilt angles, ET reconstruction always suffers from the "missing wedg...
We investigated the effects of two context variables, presentation format (icon arrays or numerical frequencies) and time limitation (limited or unlimited time), on the proportional reasoning abilitie...
The objective of this study was to compare disposable pads to Icon™ reusable underwear for the management of urinary incontinence on dimensions of quality of life and product performance.
Several studies have suggested that lab results have minimal impact on clinical decision-making in surgery. Despite the widespread use of preoperative testing in spine surgery and the large volume of ...
Choice behavior in humans has motivated a large body of research with a focus on whether decisions can be considered to be rational. In general, humans prefer having choice, as do a number of other sp...
The aim of this study is to determine the effect of ICON on White spot lesions compared to CPP-ACPF plus.
The purpose of this study is to evaluate the safety and effects of repeated intravitreal injections of ICON-1 0.6 mg administered as maintenance therapy or in combination with aflibercept ...
This is a randomized cross over trial to compare quality of life and product performance between Icon reusable underwear versus standard disposable pad in patients with mild to moderate ur...
We include the patients who need painless invasive endoscopic precedure, we collect the dempgraphic data and apply the non-invasive device ICON on patients during the who procedure.
The aim of the study is to investigate the use of a new FDA-approved non-invasive bio-impedance cardiac monitor, ICON, to detect hemodynamic effects during sedation in children undergoing ...
For over 10 years Icon Labs has been building intelligent, networked devices for industry leaders in the Telecommunications, Networking, Medical Equipment and Consumer Electronics Industries. Our solu...
ICON was founded in 1990 by a group of experienced professionals, who were dedicated to providing the pharmaceutical and biotechnology industries with exceptional clinical research and biometric servi...
ICON Eyecare is a leading surgical and medical eye care provider, based out of Denver, CO. Since 1999, ICON has been building a Center of Ophthalmology Excellence empowered by an ...
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic devel...
ICON plc. is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic deve...
We have published hundreds of ICON LABS news stories on BioPortfolio along with dozens of ICON LABS Clinical Trials and PubMed Articles about ICON LABS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ICON LABS Companies in our database. You can also find out about relevant ICON LABS Drugs and Medications on this site too.